Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis

N Sawada, JK Liao - Antioxidants & redox signaling, 2014 - liebertpub.com
Abstract Significance: The 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors or
statins are important therapeutic agents for lowering serum cholesterol levels. However …

Rho kinase: an important mediator of atherosclerosis and vascular disease

Q Zhou, JK Liao - Current pharmaceutical design, 2009 - ingentaconnect.com
Atherosclerosis is a complex inflammatory process characterized by the cross-talk between
excessive inflammation and lipid accumulation. In the past few years, compelling evidence …

Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease

Q Zhou, C Gensch, JK Liao - Trends in pharmacological sciences, 2011 - cell.com
ROCKs are important regulators of the actin cytoskeleton. Because changes in the actin
cytoskeleton underlie vascular contractility and remodeling, inflammatory cell recruitment …

Statins inhibit Rho kinase activity in patients with atherosclerosis

A Nohria, A Prsic, PY Liu, R Okamoto, MA Creager… - Atherosclerosis, 2009 - Elsevier
BACKGROUND: In addition to inhibiting cholesterol synthesis, statins (HMG-CoA reductase
inhibitors) decrease the formation of isoprenoid intermediates required for the activation of …

Rho kinase (ROCK) inhibitors

JK Liao, M Seto, K Noma - Journal of cardiovascular …, 2007 - journals.lww.com
The Rho kinase (ROCK) isoforms, ROCK1 and ROCK2, were initially discovered as
downstream targets of the small GTP-binding protein Rho. Because ROCKs mediate various …

[HTML][HTML] Striking crosstalk of ROCK signaling with endothelial function

K Noma, Y Kihara, Y Higashi - Journal of cardiology, 2012 - Elsevier
Rho-associated coiled-coil forming protein kinases (ROCKs), the downstream target
proteins of RhoA, are ubiquitously expressed serine-threonine protein kinases. ROCKs have …

Physiological role of ROCKs in the cardiovascular system

K Noma, N Oyama, JK Liao - American Journal of …, 2006 - journals.physiology.org
Rho-associated kinases (ROCKs), the immediate downstream targets of RhoA, are
ubiquitously expressed serine-threonine protein kinases that are involved in diverse cellular …

Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm

M Dong, BP Yan, CM Yu - Cardiovascular & Hematological …, 2009 - ingentaconnect.com
Rho-kinase (ROCK) is one of the effectors of the small GTP-binding protein Rho.
Accumulating evidence suggests that the Rho/ROCK system may play an important role in …

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial …

PY Liu, YW Liu, LJ Lin, JH Chen, JK Liao - Circulation, 2009 - Am Heart Assoc
Background—By inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, statins not
only reduce cholesterol biosynthesis but also decrease the formation of isoprenoids, which …

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases

M Dong, BP Yan, JK Liao, YY Lam, GWK Yip… - Drug discovery today, 2010 - Elsevier
The Rho/rho-kinase (ROCK) pathway has an important role in the pathogenesis of several
cardiovascular diseases. The activation of ROCK is involved in the regulation of vascular …